European guidelines on perioperative venous thromboembolism prophylaxis: Aspirin

Area of Science:

• Orthopedic Surgery
• Pharmacology
• Thromboprophylaxis

Background:

• Venous thromboembolism (VTE) is a significant risk following orthopedic procedures.
• Current guidelines suggest aspirin as a viable option for VTE prophylaxis in specific orthopedic contexts.
• Low molecular weight heparin (LMWH) is a common standard for VTE prevention.

Purpose of the Study:

• To evaluate the efficacy and safety of aspirin for VTE prophylaxis in various orthopedic surgeries.
• To compare aspirin with LMWH and other pharmacological agents for VTE prevention.
• To assess the role of aspirin in general surgery thromboprophylaxis.

Main Methods:

• Systematic review and meta-analysis of existing studies (implied by guideline references).
• Analysis of data regarding deep vein thrombosis (DVT) and pulmonary embolism (PE) prevention.
• Assessment of bleeding rates associated with aspirin use.

Main Results:

• Aspirin is recommended for VTE prophylaxis after total hip arthroplasty, total knee arthroplasty, and hip fracture surgery (Grade 1C).
• Aspirin shows comparable or potentially lesser efficacy than LMWH for DVT/PE prevention in these procedures.
• Aspirin is associated with low bleeding rates, potentially lower than other agents, after major hip and knee surgeries (Grade 1B).
• Efficacy and safety data for other orthopedic procedures are limited (Grade 2C).
• Aspirin is not recommended for general surgery thromboprophylaxis (Grade 1C).

Conclusions:

• Aspirin is a recommended and potentially safer alternative for VTE prophylaxis in major orthopedic surgeries like hip and knee replacements.
• Further research, particularly large-scale trials, is needed to confirm aspirin's role in general surgery, especially in low-income settings.
• The findings support the use of aspirin as a cost-effective and safe option for VTE prevention in specific patient populations undergoing orthopedic procedures.